Table 1.
Patient characteristics
| Clinical/ demographic characteristic | (n = 4415) |
|---|---|
| Age (years), mean ± SD | 60.5 ± 8.2 |
| Men, n (%) | 2283 (51.7) |
| Clinical symptoms, n (%) | |
| Non-anginal chest pain | 472 (10.7) |
| Atypical angina | 3440 (77.9) |
| Typical angina | 503 (11.4) |
| Risk factors | |
| Framingham Risk Score, mean ± SD | 21.2 ± 14.8 |
| Body-mass-index, n (%) | 30.4 (5.9) |
| Hypertension, n (%) | 2829 (64.1) |
| Diabetes mellitus, n (%) | 908 (20.6) |
| Dyslipidaemia, n (%) | 2965 (67.2) |
| Family CAD history, n (%) | 1441 (32.7) |
| PAD or cerebrovascular disease, n (%) | 221 (5.0) |
| Metabolic syndrome, n (%) | 1630 (36.9) |
| Smoker (current or past), n (%) | 2256 (51.1) |
| Sedentary lifestyle, n (%) | 2280 (51.8) |
| Depression, n (%) | 868 (19.7) |
| ECG abnormalitiesa, n (%) | 340 (7.9) |
| Racial or ethnic minority groupb, n (%) | 969 (22.0) |
| Relevant medication, n (%) | |
| Beta-blocker | 1041 (24.7) |
| ACE inhibitor or ARB | 1811 (42.9) |
| Statin | 1926 (45.6) |
| Aspirin | 1905 (45.1) |
a
Includes left branch bundle block, Q-wave, ST-depression, left-ventricular hypertrophy signs. Information available in 4282 patients.
b
Racial or ethnic minority group was self-reported, with the status of ‘minority’ being defined by the patient (available in 4370 patients).
ACE, angiotensin-converting enzyme; ARB, angiotensin-receptor blocker; BMI, body mass index; CAD, coronary artery disease; CTA, computed tomography angiography; ECG, electrocardiogram; PAD, peripheral arterial disease.